The Science Behind Cancer, Roundup Herbicide and Bayer’s $10 Billion Settlement

This week, the Bayer pharmaceutical corporation agreed to pay back about $ten billion to settle authorized statements around the health and fitness effects of the herbicide Roundup. The price range will conclude around ninety five,000 lawsuits brought versus Monsanto (which Bayer purchased in 2018), though also allocating funds to examine regardless of whether Roundup results in most cancers.

Particularly, $1.25 billion will go towards impartial analysis into regardless of whether Roundup results in non-Hodgkin’s lymphoma (and at what doses). The funds is a action in the ideal direction, states Emanuela Taioli, an epidemiologist at Mount Sinai who served on the

Read More